Barak Ben Arye
Fortuna: 4 M $ al 31/07/2026
Fortuna: 4 M $ al 31/07/2026
Barak Ben Arye is currently General Counsel at NovoCure Ltd. since 2022.
Formerly, Mr. Ben Arye was a Partner at Raved, Magriso, Benkel & Co. from 2005 to 2013.
Mr. Ben Arye completed undergraduate studies at Reichman University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
NOVOCURE LTD. 0,21 % | 30/06/2026 | 243.752 ( 0,21 % ) | 4 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| NOVOCURE LIMITED | Consejero General | 01/04/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
Raved, Magriso, Benkel & Co.
Raved, Magriso, Benkel & Co. Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01/01/2013 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
NovoCure Ltd.
NovoCure Ltd. Medical SpecialtiesHealth Technology Operates as a commercial-stage oncology company | Health Technology |
Raved, Magriso, Benkel & Co.
Raved, Magriso, Benkel & Co. Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Reichman University
Reichman University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.